Calcium Phosphates As Delivery Systems for Bisphosphonates

Overview

Journal J Funct Biomater

Specialty Biomedical Engineering

Date 2018 Jan 19

PMID 29342839

Citations 23

Authors

Adriana Bigi

Elisa Boanini

Affiliations

Soon will be listed here.

Abstract

Bisphosphonates (BPs) are the most utilized drugs for the treatment of osteoporosis, and are usefully employed also for other pathologies characterized by abnormally high bone resorption, including bone metastases. Due to the great affinity of these drugs for calcium ions, calcium phosphates are ideal delivery systems for local administration of BPs to bone, which is aimed to avoid/limit the undesirable side effects of their prolonged systemic use. Direct synthesis in aqueous medium and chemisorptions from solution are the two main routes proposed to synthesize BP functionalized calcium phosphates. The present review overviews the information acquired through the studies on the interaction between bisphosphonate molecules and calcium phosphates. Moreover, particular attention is addressed to some important recent achievements on the applications of BP functionalized calcium phosphates as biomaterials for bone substitution/repair.

Citing Articles

Synthesis of Chitosan and Ferric-Ion (Fe)-Doped Brushite Mineral Cancellous Bone Scaffolds.

Yildizbakan L, Iqbal N, Giannoudis P, Jha A Biomimetics (Basel). 2024; 9(6).

PMID: 38921188 PMC: 11202294. DOI: 10.3390/biomimetics9060308.

Fabrication of Ciprofloxacin-Immobilized Calcium Phosphate Particles for Dental Drug Delivery.

Pal A, Oyane A, Inose T, Nakamura M, Nishida E, Miyaji H Materials (Basel). 2024; 17(9).

PMID: 38730839 PMC: 11084973. DOI: 10.3390/ma17092035.

The Association of Nanostructured Carbonated Hydroxyapatite with Denatured Albumin and Platelet-Rich Fibrin: Impacts on Growth Factors Release and Osteoblast Behavior.

de Lima Barbosa R, Rodrigues Santiago Rocha N, Stellet Lourenco E, De Souza Lima V, Mavropoulos E, Mello-Machado R J Funct Biomater. 2024; 15(1).

PMID: 38248685 PMC: 10817063. DOI: 10.3390/jfb15010018.

Exploring Hydrophilic PD-L1 Radiotracers Utilizing Phosphonic Acids: Insights into Unforeseen Pharmacokinetics.

Krutzek F, Donat C, Stadlbauer S Int J Mol Sci. 2023; 24(20).

PMID: 37894769 PMC: 10606431. DOI: 10.3390/ijms242015088.

Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats.

Funayama N, Yagyuu T, Imada M, Ueyama Y, Nakagawa Y, Kirita T Sci Rep. 2023; 13(1):16032.

PMID: 37749392 PMC: 10520003. DOI: 10.1038/s41598-023-43315-3.

References

Shah F, Lee B, Tedesco J, Wexell C, Persson C, Thomsen P . Micrometer-Sized Magnesium Whitlockite Crystals in Micropetrosis of Bisphosphonate-Exposed Human Alveolar Bone. Nano Lett. 2017; 17(10):6210-6216. DOI: 10.1021/acs.nanolett.7b02888. View

Boanini E, Torricelli P, Sima F, Axente E, Fini M, Mihailescu I . Strontium and zoledronate hydroxyapatites graded composite coatings for bone prostheses. J Colloid Interface Sci. 2015; 448:1-7. DOI: 10.1016/j.jcis.2015.01.088. View

Pascaud P, Gras P, Coppel Y, Rey C, Sarda S . Interaction between a bisphosphonate, tiludronate, and biomimetic nanocrystalline apatites. Langmuir. 2013; 29(7):2224-32. DOI: 10.1021/la3046548. View

Panzavolta S, Bracci B, Rubini K, Bigi A . Optimization of a biomimetic bone cement: role of DCPD. J Inorg Biochem. 2011; 105(8):1060-5. DOI: 10.1016/j.jinorgbio.2011.05.006. View

Vermeer J, Jansen I, Marthi M, Coxon F, McKenna C, Sun S . Jaw bone marrow-derived osteoclast precursors internalize more bisphosphonate than long-bone marrow precursors. Bone. 2013; 57(1):242-51. DOI: 10.1016/j.bone.2013.08.007. View

Carano A, Teitelbaum S, Konsek J, Schlesinger P, Blair H . Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest. 1990; 85(2):456-61. PMC: 296445. DOI: 10.1172/JCI114459. View

Faucheux C, Verron E, Soueidan A, Josse S, Arshad M, Janvier P . Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro. J Biomed Mater Res A. 2008; 89(1):46-56. DOI: 10.1002/jbm.a.31989. View

Fazil M, Baboota S, Sahni J, Ameeduzzafar , Ali J . Bisphosphonates: therapeutics potential and recent advances in drug delivery. Drug Deliv. 2014; 22(1):1-9. DOI: 10.3109/10717544.2013.870259. View

Ott S . Long-term safety of bisphosphonates. J Clin Endocrinol Metab. 2005; 90(3):1897-9. DOI: 10.1210/jc.2005-0057. View

10.

Verron E, Schmid-Antomarchi H, Pascal-Mousselard H, Schmid-Alliana A, Scimeca J, Bouler J . Therapeutic strategies for treating osteolytic bone metastases. Drug Discov Today. 2014; 19(9):1419-26. DOI: 10.1016/j.drudis.2014.04.004. View

11.

McClung M . Bisphosphonates. Arq Bras Endocrinol Metabol. 2006; 50(4):735-44. DOI: 10.1590/s0004-27302006000400018. View

12.

Forte L, Torricelli P, Boanini E, Gazzano M, Fini M, Bigi A . Antiresorptive and anti-angiogenetic octacalcium phosphate functionalized with bisphosphonates: An in vitro tri-culture study. Acta Biomater. 2017; 54:419-428. DOI: 10.1016/j.actbio.2017.02.040. View

13.

Gao Y, Zou S, Liu X, Bao C, Hu J . The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials. 2009; 30(9):1790-6. DOI: 10.1016/j.biomaterials.2008.12.025. View

14.

Plotkin L, Lezcano V, Thostenson J, Weinstein R, Manolagas S, Bellido T . Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo. J Bone Miner Res. 2008; 23(11):1712-21. PMC: 2648607. DOI: 10.1359/jbmr.080617. View

15.

Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A . Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol. 2006; 24(6):945-52. DOI: 10.1200/JCO.2005.04.2465. View

16.

Favia G, Pilolli G, Maiorano E . Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy. Bone. 2009; 45(3):406-13. DOI: 10.1016/j.bone.2009.05.008. View

17.

Pyo S, Kim Y, Kim C, Lee I, Park J . Bone formation on biomimetic calcium phosphate-coated and zoledronate-immobilized titanium implants in osteoporotic rat tibiae. Int J Oral Maxillofac Implants. 2014; 29(2):478-84. DOI: 10.11607/jomi.3423. View

18.

Sun F, Zhou H, Lee J . Various preparation methods of highly porous hydroxyapatite/polymer nanoscale biocomposites for bone regeneration. Acta Biomater. 2011; 7(11):3813-28. DOI: 10.1016/j.actbio.2011.07.002. View

19.

Panzavolta S, Torricelli P, Bracci B, Fini M, Bigi A . Functionalization of biomimetic calcium phosphate bone cements with alendronate. J Inorg Biochem. 2010; 104(10):1099-106. DOI: 10.1016/j.jinorgbio.2010.06.008. View

20.

Tamimi F, Sheikh Z, Barralet J . Dicalcium phosphate cements: brushite and monetite. Acta Biomater. 2011; 8(2):474-87. DOI: 10.1016/j.actbio.2011.08.005. View